GlassScriptPhysician profile
Scott A Buchanan
NPI 1932154135
$11,980.12
in general payments reported to CMS, 2019-2025
12 companies · $5,093 in 2025
The $5,093 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $779 · 2021: $2,760 · 2022: $606 · 2023: $579 · 2024: $1,407 · 2025: $5,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,090 · Food and Beverage: $1,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,089.99 |
| Food and Beverage | $1,988.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,811.72 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Carpentier-Edwards Perimount Magna Ease Pericardial Bioprosthesis - Aortic |
| Artivion, INC. | $2,037.91 | 2025 | Amds-Ascyrus Medical |
| Abbott Laboratories | $1,994.48 | 2024-2025 | Navitor, Epic |
| Medtronic, INC. | $1,233.89 | 2024-2025 | Corevalve Evolut R |
| Powerlink Ai, INC. | $633.41 | 2025 | |
| Abiomed | $584.05 | 2019-2023 | Impella |
| Bolton Medical INC | $270.13 | 2022-2025 | Treo Abdominal Stent-Graft System |
| Livanova USA, INC. | $159.10 | 2019 | |
| Organogenesis INC. | $105.14 | 2022-2023 | Puraply |
| Karl Storz Endoscopy-America | $96.28 | 2021 | |
| Ethicon US, LLC | $48.01 | 2023 | Prolene |
| Intuitive Surgical, INC. | $6.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Buchanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.